Articles related to COLORECTAL CANCER (CRC)

In a phase 2 study of patients with locally advanced mismatch repair–deficient colon cancer, treatment with neoadjuvant nivolumab plus ipilimumab resulted in a 98% pathological response rate and a 68% pathological complete response rate, with no recurrence of disease observed over a median follow-up of 26 months.

Recent findings suggest extending follow-up colonoscopy intervals to 15 years for patients without a family history of colorectal cancer and with initial negative results. This could reduce unnecessary procedures without significantly increasing cancer risk.

Microscopic colitis, often masked in routine diagnostic evaluations, necessitates a histological approach for accurate diagnosis. The disease’s association with specific medications underscores the need for careful patient medication reviews.

In the evolving landscape of colorectal cancer screening, recent evidence suggests a critical reevaluation of the benefits and risks of routine surveillance colonoscopies in patients over 70, emphasizing the importance of individualized patient care.

Abdominal cancer is no longer an ailment confined to older demographics, with a notable uptick in cases among younger adults. Physicians are urged to consider early screening, especially for patients with familial cancer histories, amidst growing concerns over lifestyle and environmental influences.

Explore the intersection of technology and gastroenterology with the CADEYETM AI system, enhancing adenoma detection in colonoscopies.